{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T19:39:36Z","timestamp":1775590776755,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["PL2024H153"],"award-info":[{"award-number":["PL2024H153"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872236"],"award-info":[{"award-number":["81872236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52272273"],"award-info":[{"award-number":["52272273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ijbiomac.2026.150649","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T22:47:22Z","timestamp":1769986042000},"page":"150649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["CD24 overexpression confers resistance to Pyrotinib through inhibiting autophagy in patients with HER2-positive breast cancer"],"prefix":"10.1016","volume":"346","author":[{"given":"Yue","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinglu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangdi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xichuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenkun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.150649_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0010","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/cancers15010051","article-title":"Systemic therapy for HER2-positive metastatic breast cancer: current and future trends","volume":"15","author":"Vega Cano","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(19)30568-6","article-title":"Pyrotinib versus lapatinib in HER2-positive breast cancer","volume":"20","author":"Gourd","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1288362","article-title":"Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)","volume":"15","author":"Bao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0030","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10120-020-01126-9","article-title":"Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor\/c-kit signaling and its downstream pathways","volume":"24","author":"Su","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076065","article-title":"Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial","volume":"383","author":"Ma","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0040","article-title":"Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer","volume":"8","author":"Guan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0045","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-22-0283","article-title":"Molecular pathways and mechanisms of HER2 in Cancer therapy","volume":"29","author":"Raghav","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.critrevonc.2019.05.001","article-title":"Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: current knowledge, new research directions and therapeutic perspectives","volume":"139","author":"Vernieri","year":"2019","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100903","article-title":"A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+CD24- enriched breast cancer stem-like cells","volume":"66","author":"Liu","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1570163814666170818125036","article-title":"Involvement of CD24 in multiple Cancer related pathways makes it an interesting new target for Cancer therapy","volume":"18","author":"Eyvazi","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0681-z","article-title":"CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma","volume":"9","author":"Lu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110557","article-title":"CD24 blockade as a novel strategy for cancer treatment","volume":"121","author":"Wang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0080","article-title":"Multi-scale data reveal a CD24 ( ) MUCL1( ) tumor subgroup associated with unfavorable prognosis in ER breast cancer","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0085","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20212035","article-title":"Identification of potential immunotherapy biomarkers for breast cancer by bioinformatics analysis","volume":"42","author":"Song","year":"2022","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0090","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021110031","article-title":"The multifaceted role of autophagy in cancer","volume":"41","author":"Russell","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0095","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/med.21531","article-title":"The multifaceted role of autophagy in cancer and the microenvironment","volume":"39","author":"Folkerts","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1662","article-title":"Inhibition of autophagy antagonizes breast cancer brain metastogenesis and augments the anticancer activity of lapatinib","volume":"14","author":"Nawrocki","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0105","article-title":"Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0110","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/tox.23509","article-title":"A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis","volume":"37","author":"Wang","year":"2022","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0115","doi-asserted-by":"crossref","first-page":"942","DOI":"10.7150\/ijbs.57164","article-title":"Ferroptosis-related genes for overall survival prediction in patients with colorectal Cancer can be inhibited by Gallic acid","volume":"17","author":"Hong","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01716-y","article-title":"CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer","volume":"22","author":"Xing","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0125","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein-protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-0787-y","article-title":"CD24 associates with EGFR and supports EGF\/EGFR signaling via RhoA in gastric cancer cells","volume":"14","author":"Deng","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0135","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.tibs.2017.09.002","article-title":"The ubiquitin code in the ubiquitin-proteasome system and autophagy","volume":"42","author":"Kwon","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113292","article-title":"Role of SALL4 in HER2+ breast Cancer progression: regulating PI3K\/AKT pathway","volume":"23","author":"Pattanayak","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0145","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s40265-018-0997-0","article-title":"Pyrotinib: first global approval","volume":"78","author":"Blair","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0150","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.33249","article-title":"Novel insights into the function of CD24: a driving force in cancer","volume":"148","author":"Altevogt","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13058-021-01444-5","article-title":"High-throughput surface marker screen on primary human breast tissues reveals further cellular heterogeneity","volume":"23","author":"Virtanen","year":"2021","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0160","doi-asserted-by":"crossref","first-page":"38294","DOI":"10.18632\/oncotarget.16203","article-title":"CD24 expression and differential resistance to chemotherapy in triple-negative breast cancer","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdu359.5","article-title":"Effect of Her2 overexpression on cancer stem-like characteristics of triple-negative breast cancer cells","volume":"25","author":"Hosonaga","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96449-7","article-title":"Translocation of intracellular CD24 constitutes a triggering event for drug resistance in breast cancer","volume":"11","author":"Huth","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0175","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41401-024-01419-0","article-title":"STT3-mediated aberrant N-glycosylation of CD24 inhibits paclitaxel sensitivity in triple-negative breast cancer","volume":"46","author":"Wang","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061447","article-title":"The multifaceted functions of autophagy in breast Cancer development and treatment","volume":"10","author":"Niklaus","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41568-021-00344-2","article-title":"Autophagy in tumour immunity and therapy","volume":"21","author":"Xia","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0190","article-title":"Pyrotinib and chrysin synergistically potentiate autophagy in HER2-positive breast cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ebiom.2015.01.008","article-title":"Decreased BECN1 mRNA expression in human breast Cancer is associated with estrogen receptor-negative subtypes and poor prognosis","volume":"2","author":"Tang","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0200","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1073\/pnas.1717800115","article-title":"Increased autophagy blocks HER2-mediated breast tumorigenesis","volume":"115","author":"Vega-Rub\u00edn-de-Celis","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0205","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1164-5","article-title":"Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation","volume":"38","author":"Mele","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0210","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.4161\/cc.10.22.17976","article-title":"Autophagy positively regulates the CD44(+) CD24(\u2212\/low) breast cancer stem-like phenotype","volume":"10","author":"Cuf\u00ed","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0215","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0220","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/15548627.2017.1290751","article-title":"New frontiers in the treatment of colorectal cancer: autophagy and the unfolded protein response as promising targets","volume":"13","author":"Mokarram","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.ijbiomac.2026.150649_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.729212","article-title":"Case report: significant efficacy of Pyrotinib in the treatment of extensive human epidermal growth factor receptor 2-positive breast cancer cutaneous metastases: a report of five cases","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026005751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026005751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:34:56Z","timestamp":1770960896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026005751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"alternative-id":["S0141813026005751"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150649","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD24 overexpression confers resistance to Pyrotinib through inhibiting autophagy in patients with HER2-positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150649"}}